Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Absci (Nasdaq: ABSI) will present at the 44th Annual J.P.

Rhea-AI Summary

Absci (Nasdaq: ABSI) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Management is scheduled to present on Wednesday, January 14, 2026 at 3:45 p.m. PT (6:45 p.m. ET). Interested parties can watch a live and archived webcast via the company's investor relations site at investors.absci.com.

The presentation will cover the company's clinical-stage programs and AI-driven therapeutic platform; a webcast will be available for on-demand viewing after the presentation.

Argus Dec 16 session

+4.72% close to close Open Argus

Details

News Market Reaction – ABSI

On Dec 16, the day this news came out, ABSI closed 4.72% above the previous close.

Data tracked by StockTitan Argus for the Dec 16 session.

Key Figures

Conference date: January 14 Presentation time PT: 3:45 p.m. Pacific Time Presentation time ET: 6:45 p.m. Eastern Time

Conference date

January 14

Scheduled presentation date at 44th Annual J.P. Morgan Healthcare Conference

Presentation time PT

3:45 p.m. Pacific Time

Scheduled time for management presentation

Presentation time ET

6:45 p.m. Eastern Time

Corresponding Eastern Time for webcast

Historical Context

5 past events · Latest: Dec 11

5 events

1. Dec 11

   Scientific data update

   24h Move

   -3.3%

   New human ex vivo ABS-201 data suggesting potential to reverse follicle miniaturization.

2. Dec 10

   Awareness partnership

   24h Move

   +12.8%

   Partnership with Landon Donovan to highlight hair loss patient voice and ABS-201 program.

3. Dec 04

   Clinical trial start

   24h Move

   +11.7%

   First participants dosed in Phase 1/2a HEADLINE trial of ABS-201 for AGA.

4. Nov 12

   Earnings and updates

   24h Move

   -1.4%

   Q3 2025 results with lower revenue and sizeable net loss alongside pipeline updates.

5. Oct 29

   Earnings scheduling

   24h Move

   -0.7%

   Announcement of timing for Q3 2025 results call and webcast logistics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

generative AI

1 terms

generative AI technical

"a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI"

Generative AI is a type of computer technology that can create new content, like text, images, or music, on its own. It’s important because it can produce realistic and useful material quickly, which could change how we create art, write stories, or even develop new products. Think of it as a smart robot that can invent and produce things almost like a human.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, Wash. and NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the upcoming 44^th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Absci management is scheduled to present on Wednesday, January 14^th at 3:45 p.m. Pacific Time (6:45 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company’s investor relations website at: investors.absci.com.

About Absci

Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation™ platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci’s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201™, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern hair-loss. ABS-201 is also being investigated as a potential “best-in-class” therapeutic for endometriosis, a condition with significant unmet medical need and market potential. Absci is headquartered in Vancouver, WA, with an AI Research Lab in New York City, and Innovation Center in Switzerland. Learn more at www.absci.com or follow us on LinkedIn (@absci), X (@Abscibio) and YouTube.

Absci^® standard character mark, ABS-201™, and Integrated Drug Creation™ are trademarks and registered trademarks of Absci Corporation.

Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com

Media Contact
press@absci.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Absci (ABSI) present at the 44th J.P. Morgan Healthcare Conference?

Absci is scheduled to present on Wednesday, January 14, 2026 at 3:45 p.m. PT (6:45 p.m. ET).

How can investors watch Absci's (ABSI) J.P. Morgan presentation?

Investors can access a live and archived webcast on Absci's investor relations website at investors.absci.com.

What topics will Absci (ABSI) cover during the J.P. Morgan presentation?

Management will discuss the company's clinical-stage programs and generative AI therapeutic platform.

Will the Absci (ABSI) webcast be available after the conference?

Yes, an archived webcast will be available on the investor relations site after the live presentation.

Where is the 44th Annual J.P. Morgan Healthcare Conference being held?

The conference takes place in San Francisco, California.